Emrelis is the first FDA-approved treatment for previously treated patients with locally advanced or metastatic non-squamous ...

Revolution Medicines has dosed the first subject in the Phase III RASolve 301 trial with the RAS (ON) multi-selective ...

Belrestotug plus dostarlimab showed no progression-free survival benefit in NSCLC, leading GSK and iTeos to discontinue all ...

What is popcorn lung? The serious and irreversible disease linked to vaping - Vaping is especially popular among teenagers ...

The U.S. FDA granted Abbvie Inc. accelerated approval for antibody-drug conjugate (ADC) Teliso-V (telisotuzumab vedotin), newly branded Emrelis, making it the first treatment for previously treated ...

Diacetyl, or 2,3-butanedione, is a flavoring agent that becomes a toxic inhalant when aerosolized. It causes inflammation and ...

A recent study reports that disruption of tracheal basal cell homeostasis is the key cellular event driving lung squamous ...

Enriqueta Felip, MD, PhD, discusses how results from the phase 3 3475A-D77 trial evaluating subcutaneous pembrolizumab vs ...

Consequently, there are many works in the literature that explore the use of neural networks for the segmentation of lung nodules. However, these frameworks tend to rely on accurate labelling of the ...

Afatinib has broad activity against EGFR mutations. However, the approval for uncommon mutations was based on data from 38 ...

Results from phase 2 trials appear to support the use of chemotherapy-free regimens in patients with osimertinib-resistant ...

Keytruda is set to lose exclusivity in 2028, meaning Summit may face competition from cheaper biosimilars. Meanwhile, other ...